OÜ Kantremaa Apteek
RegisteredKey figures
Ratios
2025Summary: OÜ Kantremaa Apteek
What kind of company is it?
OÜ Kantremaa Apteek (registry code 12874796) is a private limited company (OÜ). The company was entered in the Commercial Register in 2015 and has been registered for 11 years. Registered location: Viljandi linn, Viljandi maakond. According to the latest annual report, the main activity is retail sale of pharmaceutical products (EMTAK 47731). The company is registered for VAT (VAT number EE101803892).
How is the company doing financially?
Revenue in financial year 2025 was 908 346 €, down 1,1% on the previous year (917 990 €). From 2019 to 2025, revenue grew by an average of 7,3% per year. Net profit for financial year 2025 was 76 543 € (8,4% of revenue). The company was profitable in all 7 published financial years. In financial year 2025 the company had 2 employees (1 a year earlier). Revenue per employee was 454 173 €. At the end of financial year 2025, total assets were 431 760 € and equity 331 774 € (76,8% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, turnover in Q3 2026 was 240 712 €, up 17,4% on the same quarter a year earlier. The company had 3 employees in that quarter. Labour taxes paid in the quarter: 4572 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 1080 € per month.
Who runs the company and who owns it?
The management board has 2 members. According to the register, the company has 2 owners. The largest stake (70%) is held by a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 30.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 240 712 € | 3 | 4572 € |
| Q2 2026 | 208 959 € | 3 | 4921 € |
| Q1 2026 | 228 352 € | 3 | 3893 € |
| Q4 2025 | 254 885 € | 3 | 4607 € |
| Q3 2025 | 205 092 € | 3 | 4483 € |
| Q2 2025 | 211 882 € | 3 | 4478 € |
| Q1 2025 | 249 363 € | 3 | 4768 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculatedDistributed as dividends 39 400 € (13% of distributable profit).
Summary of financial statements2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 714 007 | 786 000 | 793 430 | 917 990 | 908 346 |
| Net profit | 61 347 | 67 242 | 75 610 | 90 699 | 76 543 |
| Retained earnings | 158 252 | 181 548 | 209 516 | 201 432 | 252 731 |
| Total assets | 267 638 | 329 061 | 344 982 | 368 919 | 431 760 |
| Total liabilities | 45 539 | 77 771 | 57 356 | 74 288 | 99 986 |
| Total equity | 222 099 | 251 290 | 287 626 | 294 631 | 331 774 |
| Employees | 1 | 1 | 1 | 1 | 2 |
| Average gross salary (monthly) | 2392 | 2491 | 2561 | 2019 | 1353 |
| Calculated dividend | 29 572 | 38 051 | 39 274 | 83 694 | 39 400 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Selver AS622 m €
- ORLEN Eesti OÜ609 m €
- AS Alexela555 m €
- Coop Eesti Keskühistu549 m €
- aktsiaselts Olerex543 m €